Dell Technologies Inc. (NYSE: DELL): What EMC’s $984.3 m Air Force award means for defense IT strategy
Read More Pharma Industry News How recombinant therapies are reshaping bleeding disorder treatment for children in 2025 Recombinant therapies are replacing plasma-derived treatments for pediatric bleeding disorders—see what’s driving this shift in 2025 and who’s leading. byPallavi MadhirajuSeptember 10, 2025